Clinical Study

Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries

Figure 2

Survival curves at different stages of HIV care. Kaplan-Meier survival curves by entry into care within 3 months (a), by retention in pre-ART care (b), by retention in pre-ART care of patients with initial CD4 count 250–350 (c), >350 (d), by ART initiation within 3 months of becoming eligible (e), by ART initiation within three months of patients with CD4 count >200 (f), 50–200 (g), <50 (h), and by virological suppression in the last viral load determination (i). ART, antiretroviral therapy; CD4, CD4 count in cells/μL; c/mL, copies/mL.
384805.fig.002a
(a)
384805.fig.002b
(b)
384805.fig.002c
(c)
384805.fig.002d
(d)
384805.fig.002e
(e)
384805.fig.002f
(f)
384805.fig.002g
(g)
384805.fig.002h
(h)
384805.fig.002i
(i)